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Using immunocytochemistry and Northern blot anal-
ysis, we investigated the role of cell morphology and 
reorganization of the cytoskeleton in the expression 
of transforming growth factor-/31 (TGF-/H) in human 
dermal fibroblasts. Disruption of the cytoskeleton 
was induced by three different agents-trypsin, ethyl-
eneglycol-bis(/3-aminoethyl ether)-N ,N ,N' ,N' -tetraace-
tic acid (EGTA), or cytochalasin-and was confirmed by 
staining with rhodamine-labeled phalloidin. Inununo-
cytochemical staining with antibodies specific for 
TGF-/31 revealed a cell-shape-related induction of 
TGF-/31. Northern blot analysis of total RNA showed a 
significant increase in the expression ofTGF-/31 mRNA 
as early as 4 h and peaking at 12 h after disruption of the 
cytoskeleton. Quantitative analysis of TGF-/31 mRNA 
expression at 4 h after treatment with trypsin, EGTA, or 
cytochalasin C showed increases of 2.6-, 3.3-, and 2.6-
fold, respectively. Disruption of the cytoskeleton by 
I n recent years, it has becom e apparent that cytokines, including transtorming growth fac tor-f3 (T GF-f3), play a crucial role in wound healing and tissue remodeling. TGF-f31 is a po tent chemotactic fa ctor for fibrobl as ts [1] and inSammatory ceUs [2,3]. It also stimulates proliferation of 
im mature fibroblas ts [4], resulting in an increased fibrobla st popu-
lation , the main cellular source o f extracel1ular matrix (ECM) 
components at the site of injury. T GF-f31 stimulates the syn thesis of 
maj or matrix components in cl uding collagens, fibronectin [5,6], 
and p roteoglycans [7] . It also stimulates the production of protein-
ase inhibi to rs, including plasminogen activato r inhibitor [8] and 
tissue inhibitor of metaUoproteinases (T IMP) , and inhibits the produc-
tion of matrix proteinases such as col1agenase [9] and plasminogen 
activator [1 0). CoUectively, th ese biologic activities lead to the accu-
mulation and stabilization of the nascent matrLx, which is vital to 
wound healing. 
Although repara tive fun ctions of TG F- f31 are benefi cial to 
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trypsin, EGTA, or cytochalasin C increased mRNA for 
collagenase by 3.S-fold, 2.3-fold, or 2.S-fold, respec-
tively. The expression ofmRNA for tissue inhibitor of 
metalloproteinases I (TIMP-I) also showed a 3.2-fold 
increase by trypsin, a 3.6-fold increase by EGTA, and a 
2.S-fold increase by cytochalasin C. Cell-shape-related 
induction of TGF-/31, collagenase, and TIMP-I genes 
appears to be selective, as the levels of mRNA for 
fibronectin and type I pro collagen were not signifi-
candy altered. These data suggest that gene expression 
ofTGF-/31, collagenase, and TIMP-I is governed by the 
status of the cytoskeleton micro.6.lament organization, 
which may be a mechanism of gene regulation during 
cell division, migration, and differentiation, events fun-
damental to wound healing. Key words: cytoskeleton/gene 
expression/extracell"lar matrix/dermal.libroblast. ] Invest Der-
matoI104:118-123, 1995 
wound healing [11,1 2], overactivity of this growth factor could be 
responsible for scarring and fibrosi s. Overaccumulation of ECM, 
changes in ECM components and architecture, and activated fibro-
blasts are hallmarks of fibroproliferative disorders. W e have reported 
recently that TGF-f31 is overexpressed in post-bulll hypertrophic scars 
(HSc) [13] . Elevated levels of TGF-f31 in v31ious fibrotic conditions 
[13-16] and the suppression of fibrotic activity by neutralizing the 
activity ofT GF-f31 ;/1 lIi llO [17] provide evidence for its involvement in 
the pathogenesis of fibroproliferative disorders. 
D espite progress in defining the biologic activities of TGF-f3 in 
health and disease, the m echanisms that regulate TGF-f3 synthesis 
are not ye t clear. Several factors such as diffe rentiation [18], oAl'gen 
tension [19], cytokines including TGF-f3 itself [20], members of the 
steroid hormone superfamily [21], and ECM components [22] may 
be involved .in regulation o f TGF-f3 expression. The ECM no t only 
serves as a scaffold for cells but also controls cell shape and regulates 
many cellular function s by w ay . of the cell cytoskeleton. The 
cytoskele ton wldergoes remarkable ch anges during cell division, 
cell migration, and differentiation, events fund am ental to wound 
healing. Alterations in the cyt~skeleton subsequently affect ce ll-
m atrix and cell-cel1 interactions, resulting in changes in cellular 
phenotype and fun ction. In tills study, we examined the role of 
alterations in the cytoskele ton on the expression of TGF-f31 in 
dermal fibroblasts. Alterations in th e cytoskele ton w ere induced 
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by trypsin, ethyleneglycol-bis({3- aminoethyl ether)-N ,N ,N ' ,N'-
te traacetic acid (EGTA), or cytochalasin. 
MATEIUALS AND METHODS 
Cell Culture Cultures of fibroblasts from normal and hypertrophic scar 
tissue were establi shed as described previo usly [23]. In tlus study, we used 
paired HSc and normal dermal fibroblast cultures from passages 4 to 7. 
Antibodies and Probes Two polyclonal anti-TGF- J31 antibodjes, anti-
CC and anti-LC , and similarly prepared nonimmunc IgG were provided by 
Kathleen C. Flanders (Nationa l Can cer Institute, NIH, Bethesda, MD) . The 
specifi city of these antibodies has been examined by W estern blot, radio-
immunoassay, en zym e-linked immunosorbent assay, and immunolusto-
chemistry [24]. It is believed that anti-CC principally recog.u zes extracel-
lu lar TGF-J3, whereas anti-LC reacts with intracellular TGF-J3 . The 
complem entary DNA (cDNA) probe for TGF-J31 was a donati <:> n of Dr. G. !. 
Bell (Howard Hughes Medical Institute, Department of Biod1emistry and 
Molecular Biology and Medicine, Unjversity ofClu cago, C lucago, IL). The 
type I procollagen cDNA probe was provided by Drs. G. Tromp, H . 
Kuivanjemi , and L. Ala-Kokko (Department of Biochemistry and Molecular 
Bio logy, J efferson Institute of Molecular Medicine, Plu ladelplua, PA) . T he 
probes for human fibronectin, TIMP, and collagenase w ere purchased from 
American Type Culture Collection (ATCC, Rockvil le, MO) . 
Disruption of Cytoskeletal Organization Disruption in cytoskeleta l 
orga,uzation was induced by trypsin , EGTA (S igma, St. Loujs, MO) , or 
cytochalasin C (S igma) . C0I1fluent cells w ere harvested from culture flasks 
using either 3 ml ofO.l'Yo trypsin and 0.02'X, e thylenediamjne tetraacetic acid 
(Sigma) ill phosphate-bufrered saline (PBS) (pH = 7.4) for 3 min, or 6 ml 
of 0.05% EGTA in Hanks' balanced sa lt solution for 45 nID1. Cells were 
washed twice with Dulbecco's modifica tion of Eagle's medium plus 10%, 
fe tal bovine serum (DME + 10% FBS) , resuspended in the same media, and 
replated by spljtting 1 :3. After 4 h, cells were used for total RNA extraction . 
To examjne the time course ofTGF-J31 mRNA expression, the tota l RNA 
was ex tracted from trypsi.u zed cells after replating for 4, 8, 12, 24, and 96 h 
(confluent culture). Cytochalasin C (Sigma) was first dissolved in 95% 
ethano l (1 m g/m l) and used in a fina l concentration of 1 J..1,g/m l in DME + 
10% FBS . Confluent cell s were treated witl1 cytochalasin C for 4 h. At the 
end of tlus period, cell s were washed with PBS for 2 min and inunediately 
llsed for RNA extraction. The viability of cytochalasi.n- treated cel.ls was 
more than 90% as judged by trypan blue dye exclusion and by recovery of 
cells after rep lacement of the medium . 
Imm n nocytochelnistry A rabbit peroxidase anti-peroxidase immuno-
staining ki t (Zymed, SOUtl1 San Francisco, CAl was used to localize and 
detect TGF- J31. Cells were seeded on glass coverslips (22 mm X 22 mm) 
and allowed to grow for 4 or 24 h in DME + 10% FBS. T he coverslips tl1en 
were removed from the medjum and fixed in 4% parafom1aldehyde in PBS 
for 18 h at 4°C. Cells fixed on coverslips were washed twice in PBS for 5 
min each, and endogenous peroxidase was blocked with hydrogen perox-
ide/methanol. After permeabili zatioll with 0.05% polyo;\,:yetl1ylene sorbitan 
(Tween 20) in PI3S, nonspecifi c binding was blocked with 10% norma'! goat 
serum. T he covers lips were then treated with the primary antibod.ies, rabbit 
anti-CC (12 .5 ng/m l) , or anti-LC (40 ng/ml) for 18 h at 4°C in a humidified 
chamber. T he coverslips were washed w ith PBS and treated with bridging 
antibody, goat anti-rabbit IgG. After washing, the coverslips w ere trea ted 
with peroxidase anti-peroxidase complex, sta in ed with 3-3' diam.inobenzi-
dine so lution and hydrogen peroxide, and lightly counterstained with 
hemato"l'l in . [n negative contro ls, primary antibodies were rep laced with 
norummune normal rabbit IgG. 
Visualization of Cellular Actin Filaments The organization of cyto-
skeleton actin filaments was visualized by stainjng with rhodamine-labeled 
phalloidin. Confluent cells were harvested by either trypsin or EGTA and 
replated for 4 o r 24 h on sterile coverslips. Some of the 24-h culu.res were 
treated with 1 J..1,g/ ml of cytocha lasin C in DME + 10% FBS for 4 h. T he 
coverslips then were fixed in 4% parafonmtldehyde in PBS at r00111 
temperature for 3 h . Cells were washed in PBS and treated with a 1 :200 
djlution of stock solution of tetmrhodamine isotl1iocya.1ude-Iabeled phallo i-
din (50 J..1,g/ ml 70% ethanol) (Sigma) for 15 min in the dark . After washing, 
they were mounted on glass slides with glycoIlP-phenylenediamine. 
RNA Extraction and Northern Blot Analysis Fibroblast cell layers 
were lysed and pooled in 6 ml of 4 M gua'1idjnium iso tluocyanate solution, 
and total RNA fi'om each individua l cell lysate was isolated by the 
guanidinium isotluocyanate/CsCI procedure of C hjrgwin el nl [25]. Total 
RNA fi'om each individual fibrob last culture then was separated by 
electrophoresis (8 J..1,g per lane) on a 1% agarose gel containing 2.2 M 
formaldehyde and blotted onto nitrocellulose filters. To ensure that the gel 
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lanes were loaded with similar amounts of total RNA , the quantities of18S 
and 28S ribosomal RNA were compared visually by ethidium bromide 
fl uorescence. The blots were baked for 2 h at 80°C under a vacuum and 
then prehybridized for 4 h at 42°C in a prehybridization solution. Hybrid-
ization was performed at 42°C in the sam e solution for 16-20 h using either 
human TGF- J31 , fibronectin , type I procollagen, collagenase, or TIMP-[ 
cDNA probes. The cDNA probes were labeled with 32P-alpha-dCTP by 
njck- translation. The filters w ere washed i.utially at room temperature with 
2 X sodium citrate/sodjum chloride buffer and 0.1% sodium dodecylsulfate 
for 1 h and finally washed fo r 30 mjn at 65°C in 0.2 X sodium citrate/ 
sodium chloride buffer and 0.1% sodium dodecylsulfate. All toradiography 
was performed by exposing Kodak X - Omat film to tl1e nitrocellu.!ose fi lters 
at - 70°C in the presence of an intensifying screen. Quantitative an alysis of 
autoradiographs was accomplished by densitom etry. Because the expression 
of fibronectin mRNA is not altered by each treatment, loading of total 
RNA also was normalized by using the cDNA probe fo r fibronectin, wluch 
corresponded well witl1 tl1e etludiu1l1 bromide method of controlling 
loading. 
TGF-/3 Growth-Inhibition Assay T he mink-lung epitheljal cell (CC1 -
64, America.11 tissue culture type) growth-inhibition assay and preparation of 
conditioned media were conducted according to Daaielpour el nl [26]. 
Briefly, subconfluent cul tures were trypsinized, washed in assay media 
(DME, 0.2% FBS, 10 mM N-2-hydro"l'ethylpiperazine-N ' -2-etha.11eslu-
fonjc acid, a.nd 1% penicillin /streptomycin antibio tic), seeded at 5 X 
105 / 0.5 m l per w ell in 24-well plates, and incubated for 1 h at 37°C in a.1l 
a01lOsphere of 10% CO2 , At the end of this incubation period, the 
serum-free conditioned m edia (natural or acidified) or a standard amount of 
TGF-J31 was added, and 22 h later the cell s were pulsed with 0.25 J..1,Ci of 
3H-Iabeled thymidine per well for 2 h at 37°C. Cells tl1en were fixed and 
washed, and the radioactivity was measured in the cell lysate collected from 
each well. All samples were assayed in triplica te . 
Statistical Analysis D ifFerences in mRNA expression of different ce ll 
populations, as measured by densitometry on N ortl1em blots , were tested 
using Student paired t test; J1 < 0.05 was considered signjficant. 
RESULTS 
In1.1nunocytochem.ical Staining As shown in Fig 1 , nOl-mal 
fibroblasts seeded for 4 h showed intense staining with anti-CC (a) 
and anti-LC (c) antibodies specific for TGF-{31. In contrast, cells 
seeded for 24 h exl-ubited little or no staining with these antibodies 
(b a/ld d, respectively) . T h ere is an apparent association between cell 
morphology and the expression of anti-CC- and anti-LC-reactive 
TGF-{31 in dermal fibroblasts, as there was a remarkable difference 
in morphology between the cells seeded for 4 h and the cell s seeded 
for 24 h . In addition, w e observed that at tile cen ter of 24-h 
Figure 1. Immunocytochemical staining of anti-CC-reactive (a,b) 
and anti-LC- reactive (c,d) TGF- /31 in cultured d ermal fibroblasts_ 
Cells w ere seeded for 4 h (n, e) or 24 h (b,d) on glass coverslips, fixed , and 
processed as described in the text. Bm', 100 J..1,m. 
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cul tures, the cell s that exhibited a bipolar shape and more cell-cell 
contact did not express anti-CC- and anti-LC-reactive TGF-{31 (b 
a/ld d, respectively) . [n contrast, at the periphery of these cultures, 
the cell s th at presented a polygonal shape and less cell-cell contact 
stained with both antibodies . Anti-CC antibody is known to detect 
principally extracellular TGF-{31. However, intraceUular anti-CC-
reactive TGF-{31 was found in tlus study. A similar observation was 
reported earlier by Kane e/ al [27] in the wounded epidermis 24 h 
after injury. The expression of anti-CC- and anti-LC-reactive 
TG F-{31 in HSc cells under the above conditions was similar to that 
of normal cells (data not shown). 
Actin Filament Organization Figure 2 shows the organiza-
tion of filalll.entous actin in normal fibroblasts visualized by rho-
damine-labeled phalloidin, a fungal metabolite that reacts specifi-
ca ll y with fil amentous actin [28] . T he cells hal·vested by either 
trypsin (a) or EGTA (b) and replated for 4 h were mainly respread-
ing and displayed a rounded or polygonal shape with little ce ll-cell 
contact. The filamentous actin appeared to be undergoing assem-
bly, with undefined organization in respreading cells. In contrast, 
the cells seeded for 24 h (d) exlubited well-organized actin filaments in 
the fOlm of bundles, known as stress fibers [29] . These cells exhibited 
a bipolar shape with a lugh level of cell-cell contact. Confluent cells 
treated with cytochalasin C for 4 h (c) were morphologically different 
from 4-h seeded and 24-h seeded ceUs. These cells showed a perturbed 
cytoskeleton, with actin filam ents that were lmdergoing disassembly. 
N either a defin~d pattern of orgaJuzation of filamentous actin nor a 
particular cell morphology was evident in these cells. Fibroblasts from 
HSc dermis exlubited similar cytoskeletal orgaJuzation and cell mor-
phology in the above conditions (data not shown) . 
Northern Analysis of TGF-131 mRNA As shown in Fig 3, 
trypsinized cells replated for 4 h (/a/l es H ' , N') showed a significant 
in crease (268'% ± 45'Yc), n = 4, P < 0.05) in TGF-{31 mRNA (2 .5 
kb) as compared to their confluent counterparts (/a/l es H, N). When 
the same blot was rehybridized with a cDNA for fibronectin, the 
trypsinized cells and confluent cells showed a similar level of 
fibron ectin mRN A (7.8 kb) . To examine whether the increase in 
the expression ofTGF-{31 mRNA is due to disassembly/reassembly 
of cytoskeleton or is a trypsin-induced effect, we harvested ce lls 
usin g EGT A, a chelating agent. As shown in Fig 4 , EGT A-treated 
cell s (A, Imles H E, NE) showed a significant increase (336% ± 67%, 
n = 4, P < 0.05) in the expression ofTGF-{31 mRNA as compared 
to their confluent counterparts (Ia/l es H , N). We observed similar 
results when w e used cytochalasin C, which inlubits the assembly of 
actin microfilaments. Northern analysis of tota l mRNA extracted 
from the confluent cells treated with cytochalasin C for 4 h (Fig 
Figure 2. R11odamine-phaUoidin staining of actin microfilaments 
in dermal fibroblasts grown 011 coverslips. Cells were harvested by 
trypsin (a) or EGTA (b) and replatcd For 4 h. ConAuCllt ce lls were treated 
with cytochalasin C (c). Cells were seeded for 24 h (d) . I3ars. 50 I.un. 
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Figure 3. Expression of TGF-{31 and fibronectill mRNA in conflu-
ent (H, N) and 4-h seeded (H' ,N') cells. A) The pattern of hybridization 
with fibronectin (7.8 kb) and TGF-{31 (2.5 kb) eD NA. I-l , I-lSc; N , normal. 
B) Fluorescence photograph of the corresponding ethidium bromide-
stained gel. C) Quantitative analysis of the autoradiograms. Each bar shows 
the mean :!: standard error of the mean offour individually tested cell strains 
from I-lSc (solid, solid Itatclted bars) and normal (OJlCII , OJlCII ltatclted IJars) tissue 
in conA uent condition (cOlltrol) and the corresponding cells harvested by 
trypsin and replated for 4 h (ltatclted bars) . ' p < 0.05 . 
4A, lanes H C,N c ) showed a significant increase (262% :!: 75%, n = 
4, p < 0.05) in TGF-{31 ml~A as compared to the control (Fig 
4A, lalles H,N). The level of fibronectin mRNA remained un-
changed in EGTA- and cytochalasin C-treated cells as judged by 
hybridization of the same blot with a fibronectin cDNA (Fig 4A) . 
The etludium bromide sta ining of 28S and 18S ribosomal l~A 
(Figs 3,4B) and fibron ectin ml~A were used as loading control. 
The autoradiograms of four pairs ofHSc and normal fibroblast cell 
strains were quantitated individually using densitometry, and the 
average TGF-{3l1fibronectin ml~A ratio for treated cells was 
compared to that of confluent cells (control). A significant increase 
in TGF-{31 mRNA expression in both HSc and norma l dermal 
fibrob lasts was observed after disruption of the cytoskeleton by 
trypsin, EGTA, or cytochalasin C (Figs 3, 4C). Although both HSc 
and normal fibroblasts responded in a similar m<umer, tbe maglu-
tude of the increase in TGF-{31 ml~A was more pronounced in 
HSc fibrob lasts after trypsin and EGTA treatments. 
We also examined the effect of reorganization of the cytoskele-
ton on the time course ofTGF-{31 mR..NA expression . As shown ill 
Fig 5, Northern blot a.nalysis of tota l R.NA £i·om tt·ypsinized cells 
plated for 4, 8, 12, 24, and 96 h (confluent culture) showed a 
signifi cant increase in TGF-{31 ml~A as early as 4 h, peaking at 
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Figure 4. Expression of fibronectin mRNA (7.8 kb) and TGF-/H 
mRNA (2.5 kb) in dermal fibroblasts &0111 HSc (H) and normal (N) 
tissue after disruption of the cytoskeleton. A) Northern analysis of 
tota l RNA from conAuent ce ll s (H, f\0, ce lls harvested by EGTA and 
replated for 4 h (HE,Nc), and conAuent ce ll s treated with cytochalasin C 
(Hc,Nc). 8) Fluorescence photograph of the ethidium bromjde staining 
pattern of the original gel. C) Quantitative analysis of the autoradiograms. 
Each bar shows the mean :t standard error of the mean of four individually 
tested cell strajns from HSc (so lid, solid hatched, solid dotted bars) and normal 
(opell, opell hatcft ed, opell dOlled bars) tissuc in conAuent condition (control) 
and the corresponding cell s harvested with EGT A and replated for 4 h 
(hatched bars) or treated with cytochalasin C for 4 h «(/oll"d lidrs). ' p < 0.05. 
12 h (compared to that in confluent cell s) and signifi cantly decreas-
ing by 24 h (compared to that at 12 h) . 
TGF-fJ Growth-Inhibition Assay T he levels ofTGF-{3 protein 
secreted into the serum-free media by confluent and 24-h seeded 
cells were determined using TGF-{3 mink-lung epithe lial cell 
growth-inhibition assay. Our results showed that almost all of the 
secreted TGF-{3 was in the latent form . The level of the active form 
ofTGF-{3 in the m edia was undetectable (the sensitivity of the assay 
is in the range of 0.05-0.1 pM) . However, acidification of the 
conditioned media revealed that the concentration of TGF-{3 was 
four times (38.5 pM /1.2 X 10(, cells) g reater in 24-h cultures than 
in confl uent cultures. 
Northern Analysis of Collagenase and TIMP-I mRNA Fi-
broblasts arc the major cellular source of ECM proteins and 
enzymes involved in ECM m etabolism. Figure 6 shows the effect 
of cytoskeleton disruption on the expression of mRNA for type I 
procolJagen, a major matrix protein, and coHagenase and TIMP-I, 
two important proteins involved in ECM degradation. As shown in 
Figure 6, trypsinized cells rep lated for 4 h (Inlles H' ,N') showed 
significant increases (384% :::':: 80%, n = 4, p < 0.05 and 325'Yo :::':: 
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62%, n = 4, P < 0.05) in the expression of collagenase mRNA 
(2.1 kb) and TIMP-I mRNA (0.7 kb), respectively, as compared to 
their confluent counterparts (Inlles H,N). Similar results were seen 
when cells were treated with EGTA or cytochruasin C. Cells 
harvested by EGTA and replated for 4 h showed a significant 
increase in the expression of collagenase mRNA (238% :::':: 39%, n 
= 4, P < 0.05) and TIMP-I mKNA (365% :::':: 65%, n = 4, P < 0.05) 
as compared to their conflu ent counterparts. Confluent celJs treated 
with cytochalas in C for 4 h aJso expressed significant levels of 
collagenase mRNA (256% :::':: 48%, n = 4, P < 0.05) and TIMP-I 
mRNA (257% :::':: 35%, n = 4, P < 0.05) as compared to control. 
Although we found variation in the expression of type I procollagen 
mRNAs in trypsinized celJs (Fig 6A, C), EGT A-treated cells, and 
cytochalasin-C-treated cells (data not shown). These results sug-
gest that disruption of the cytoskeleton also induces the expression 
of collagenase mRNA and T IMP-I mRNA i.n a selective fashion. 
DISCUSSION 
Although there has been considerable progress recently in under-
standing of the intric,lte roles of TGF-13 in physiologic and patho-
logic conditions, the m echanisms that govem the expression of the 
multifunctionaJ cytokines a.re not completely lIl1derstood. In this 
study, we provide evidence to suggest that disruption of the cell 
cytoskeleton ruters mRNA expression for TGF-{31, collagenase, 
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Figu.re 5, Tittle course of expression of TGF-{31 lllRNA in dermal 
fibroblasts after disruption of the cytoskeleton. A) Northcm analysis 
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of tota l RNA from HSc (H) and normal (N) fibrob lasts. B) Fluorescence 
photograph of the corresponding ethidium brom ide stain ing pattern of the 
orig inal gel. C) Quanti tative anal ys is of the autoracUograms. Each bar shows 
the mean :t standard error of the m ean offom individua lly tested cell strains 
from HSc (solid, solid hnlched bnrs) and norma l (OpCII , opell 1/tIlcI,,'d bars) dermal 
fibrob lasts in confluent condition (control) :md the corresponding cell s 
harvested by trypsin and replated for 4 h (//tI lched bnrs). ' p < 0.05 . 
and TIMP-I. We observed ill iti aliy that cells repla ted after 
trypsinization showed very rap id induction of TGF-/31. Although 
disruption of the cytoskeleton is all immed iate and obvio us conse-
que nce of trypsinization, tbe up-regulation of TGF-/31 after this 
treatment may be caused by th e loss of some proteinase-s usceptibl e 
cell-surface component. Therefore, we tested the effects of EGT A 
and cytochalasin and found that, altho ugh both ca used a signifi ca nt 
increase in TGF-/31 mRNA, EGTA was more effective . T he 
morphology of the ce lJ s subjected to these two treatment:, was quite 
different. T he EGTA-treated cell s wel'e respreading and the mi cro-
fi laments were undergoing assembly, w he reas the cytochalasill-
treated cell s were rounding up and the microfi laments were 
undergoing disassembly. Whether the difference in the magnitude 
of the effect is due to the state of the micro filam ents or to the 
chelation of bivalent cations rema ins to be elu cidated. Apparently, 
cytoskeletal status-i11duced TGF-/31 ml~A is not part of a general 
phenomenon, as the expression of fibronectin and type (I) procol-
lagen mRNA was not significa ntl y affected by these treatments. 
Evaluation of TGF-/3 in fibrob last-conditioned media revea led 
that disruption of the cytoskele ton in creased the level of TGF- f3 
protein secreted into the media . As do most cultured normal. cells 
(30] , the dermal fibroblasts in our ill lIifro experiments also secreted 
TGF-/3 in a laten t form. Althoug h we did not detect the active form 
of thjs growth factor, this does not necessaril y impl y that TGF-/3 
secreted by derma l fibroblasts i ll IlillO is inactive. Laten t TGF-f3 ca n 
be activated by acidifi ca tion or exposure to proteases such as 
plasmin (30], and this suggests tha t the tissu e microenvironm ent 
may regu late the activation of TGF-/3 ill Il i llO. T he possible ro le of 
enzymatic cleavage of the latent TGF-/3 and the ro le of cytoskcletal 
organ ization in conditions tested in this report are under in vestiga-
tion. 
Fibroblasts regu.late the turnover of ECM vi;) the syn thesis and 
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secretion of matrix proteins, meta lloproteinases, and proteinase 
inhibitors (T IMPs). Up-regulation of coll agenase ,1Ild T IMP-[ 
m~A after disruption of the cytoskeleton reported here is un-
likely to be related to an autocrine effect of TGF-/3, as the TGF-f3 
released by these cell s in culture is not biologically active. We 
suggest that the induction of collagenase and T IM P-I ml~A is also 
cell-shape-rela ted. T h e different treatments used in this study had 
simil ar inductive effects, suggesting that the indu ction is not a 
conseq uence of trypsinization. Severa l studies have show n that 
changes in cell morphology induce expression of collagenase and 
stromelysin in cultured fibroblasts, and this indu ction has been 
attributed to th e reorganization of cytoskeletal e lements [31-33], 
altho ugh the mechanism(s) is not yet clear. W erb et al [34] prov ided 
evidence that the interaction of fibronectin with its integrin recep-
to r may be in volved. An effect of cell shape and cytoskeletal 
arch.itecture on the expression of T IMP appears no t to have been 
reported previously. 
Recently, Streuli et nl [22] showed that the absence of the 
basement mem brane specifically up-regula tes the expression of 
TGF-/31 in mammary epitheJjal ce ll s. In teractions between cells and 
matri x are mediated by membran e-spanning cell-su rface adhesion 
receptors, known as in tegrins. T he cytoplasmic domains of inte-
grins interact with actin-filament-connecting proteins such as 
vincu lin , ta lin , and O'-actinil1 , providing tJ)e linkage between the 
ECM and the cytoske leton. W e be lieve tha t the absence of ECM 
may be associated with alterations i.n cytoskeletal organ ization , 
w hjch could then be a trigger for the induction of several genes, 
including TGF-/31. 
We have reported recen tly the overexpression of TGF-/31 in 
HSc tissue [1 3]. H owever, in the present study, we noted a similar 
response to the expression of TGF-/31 in HSc and no rmal denn al 
fibrob lasts. T hu s, the overexpression of TGF-f31 in HSc tissue is 
probably due to 10caJ tactors and inAuences. We sugges t that dm;ng 
cell division, cell mig ration , and differen tiati on-fundamental 
events in tissue repair-alterations in cytoskeletal organization may 
result in the overexpression of TGF-/31. T he activation of this 
loca lly synthesized TGF-/31 may in turn propagate and perpetuate 
the stimulation of fibrob lasts via paracrine and autocl;ne mecha-
nisms, eventuall y resul ting in accumulation of ECM and fibrosis. 
T li is 1II0rk ,,,ns sll}J}J"rwl "y til e /Ilt efllnii oll ni Associnlioll oj Fire FiglIt"r's BI/I'/I 
F{)/II/rinlioll (A . GlIa"m}'), Ihe Fil'iftg",ers' Bllm T msl Flilld of Il, e Ullillersily of 
A I"ertn, tile fl /berla Heritnge FOl/l/llnlioll jin' Medicnl Resean:I, (EE. T rerlgcl, 
C lillicnl IIwesl (~al{)/1, tl/ll/''' e Nkdiral Reseal'c" CO/ II/ri! of Call tldn (E.E T redget 
amI P.G. SetHI). 
RE FER E NCES 
I. Postlethwa ite AE. Kcski-Ojn J. M osc.!s HL. Kang AH: Stimu lation or the 
chem otactic II ligratiol1 of human fibro blasts by tnmsfonning growth fol ctor 
beta. } I3xJI Med 165:25 ·1-256. 1987 
2. W" hl SM. HUll t DA. Wakefield L, McC"l'tlley-Frallcis N. Wahl LM. l1..obert, 
All, SpOrll MJ): Transforming growth f.,cro r bet;] (TGF-(3) induces monocyte 
chelllotaxis and growth f.1cto r productio n. Pmc Natl Acntl Sci USA 84:5788-
5792. 1987 
3. Ur:mdcs M E. Maiu EI-I . O hll nl K, Wahl SM: Huma n nCli trophil s express type I 
TGF-{3 receptors :md chernot:lx to TGF-{3. } 111111111110 / 147: 1 600- 1606. 1991 
4. Moses HL, Tucker I1..P, Leuf EU. Coffey RJ. Halpe r J . Shipley GO: Type beta 
transformin g: growth folcto r is a growth stiIHu1ator ;w,d a growth inhibitor . 
C llleel' C'lIs 3:65-7'1. I985 
5. Ig llotz RA. Elldo T. Massaguc j : R.cglliation of fibroncctill alld typc I coUagc l1 
rn l1..NA levels by t ransformi ng growth f:l cl.O r- {3.} lIio/ C helll 262:6443-64 46. 
1987 
(,. Varga j , H •. oscllblooJll j . Jimcnez SA: Trallsformi ng growth t:lctor {3 (TGF-(3) 
causes ,I pcrsi stent increasc in stcOldy-statc alllo unts of t)'pe I and typc III 
cotl a(;cl1 t:Hld f,broncctil1 mll....NAs in norma l human derm al fibroblilst.s. Bi()r/ICUI 
} 247:597-604. 1987 
7. 13:lssols A. M:lssagllc J: T r:1I1sforrning g rowth r.,ctor f3 regula tes the expressio ll 
and stru ctu re of cxtr:lccllu lar Ill atri.x cholldro itin / dcrl1l :u.:l1I sulfa te proteogly-
C:II1 S. J /3i,,/ C helll 263:3039-3045. 1988 
8. L:l iho M , Saksela 0, A ndrca ~cn PA . Kcski-Oja J: Enhanced produ ction and 
extracellular deposition o f the endothelial- type plasmillogen ;Ictiv:l[o r inhibitor 
VOL. 104 . NO. J ANUAR .. Y 1995 
in cultured human lun g: fi broblasts by tra nsform ing: growth f.1ctor-/3. J Cdl Bioi 
103:2403-24 10. 1986 
9. Edwards DR. Murph y G. R.eynolds JJ . Witham SE, Docherty AJP, Angel 1' . 
Heath JK: Tr:11lsforlllin g: growth f.1cwr beta modulates the expression of 
coUagcn:Isc and Illcwll oprotcinasc inhibitors. EMBO J 6:1899- 1904. t 987 
10. Laiho M. Sakscla O. Keski-Oja J : Transfonning b" owth f.,ctor (3 alters plasmin-
ogen activator activity in human ski ll fibroblasts . Exp Cdl Res 164 :399-407. 
1986 
11 . Mustoe TA, Pierce GF, Morishim:l C. Deue l TF: Growth factor induced 
acce lcralio n o f tisslie repair through direct and inductive activ ities ill a filbbit 
dermal ul cer model.) Clill hlllesl 87:694 -703. 199 1 
12. Pierce G F. Mustoe TA. Lingelbach J . Masakowski YR. Grifi'; n GL. Senior RM . 
Deuel TF: Platelet-deri ved growth r,lctor and transforming gro wth f.1c tor-bcca 
en hance tiss lIe repair :lClivitics by unique IIIcch;lI1isnu.) Cdl Bioi 109:429-440. 
1989 
13. Ghahary A. Shen YJ. Scott GP, GOllg Y. T redget EE: Enhanced expression of 
J1II'tNA for trallSfOfmill g: growth f.1ctor-!3. type III procollngct1 ill human 
post-burn hypertrophic scar ti ssue. ) L"II C/i" Mcd 122 :4 65-473. 1993 
14. Khalil N. 0 ' o llnor RN. Unruh HW . Warren PW. F1ander~ KC . Kemp A. 
13crcznay 0 1-1 . Grccllbcrg AI-): Incrc<l scd pro ducciOl I :Iud illllllllllOlliscochc lll -
ical localization of transfo rmin g growth r:lctor-/3 ill idiopathic pulmonary 
fibrosis. A lii) ResJlir Cell Mol UioI 5: 155-162 . 199 1 
15. CZ:lja MJ . \X/c iner FR. FI;mdcrs K. Giambrone M A, Wind R . Bicmpica L. Zcrn 
MA: I" vitro and ill .,il1o associa tion of transforming g rowth fac to r- /3 1 with 
hepatic fibrosis.) Cell IJio/I08:2477-2482. 1989 
16. Gruschw itz M, Mull er PU . Scpp N , Hofer E. FOUtolllil A. Wi ck G : Transcriptio n 
;md expression of tra nsforming: growth factor type beta ill the skin of 
progressive syste mic sclerosis : :t Illcdi:ltor of fi brosis. J IlIlIcst Der",alof 94 : '197-
203, 1990 
17 . Oorder WA, Okuda S. Languin o Lit. Sporn M13. Ruoslahti E: Suppression of 
experimental g lomeru lo nephritis hy antiserum against transforming growth 
I,tctor (3 1. NfllflI'e 346:37 1-374. 1990 
18. N ilsen-Hamilton M: T ransfonning gTov,Ith factor-{3 and its actions on cellular 
gro wth and differentiation. C flI' Top 01''' 8io/ 24:95- 136. 1990 
19. Fa langa V, Q ian SW . Danielpour D. Katz MH. Roberts AO. Sporn M: Hypoxia 
npregulates th e synthesis o f TGF-J3 by human dermal fibrob lasts.) Ifi lIesl 
OmflaloI97:634 -637, 199 1 
20. Obberghen-Schilling EV. 11..oche NS. Handers KC . Spom M 13 . R oberts All: 
T ransformin g: growth f.1ctor-{31 positively regu lates its OWII expression in 
nOl'l1Ial and transformed cells.) 8i,,1 ChI'''' 263:774 ·1-7746. 1988 
2 '1. Wakefie ld L. Kim SJ . Glick A. Winokur T. Colletta A. Sporn M: R egnlation of 
TGF-{3I. COLLAGENASE. AND T IMP- I IN SCAR FIOROOLASTS 123 
transforming growth f.1ctor-{3 subtypes by members of Ihe steroid hormone 
sllpel'f.1 mily. ) Cell Sci 13(Suppl): 139-148. 1990 
22 . Strellii C H. Schm.idhallser C. Kobrin M. Bissell JM , Derynck R: Extracellular 
matrix regulates expression of the TGF-{31 gene. ) Cell UioI120:253-260, 1993 
23. Ghahary A. Scott PG , Malhotra S. Friedland AU. H arrop AR. Forsyth NL. 
Tredget EE: Difierential expression of type I and type III procollagen ml1..NA 
in hllman hypertrophic bill'll fibroblasts . Billlfled 1.£11 47 ' 169-184.1992 
24. Flanders KC. T hompson NL. C issel DS, Obberghen-Schill ing EV. Baker CC, 
Kass ME. Ellingsworth LR. Roberts AB. Sporn Mll : Transforming growth 
(;,ceo1' {3 1: histochcmicallocalizatioll with antibodies 10 different cpi topcs. J Cdt 
Ui,,1 108:653-660. 1989 
25. C hirgwinJM. Przybyla A. MacDonald RT. Rutter WT: Isolation of biologically 
active ribonllcleic acid fro l1l sources cn riched in ribonucleasc. Bi(IC"r",istrJ1 
18:5294 -5299. 1979 
26. Danielpour D. Dart LL. Flanders KC. Roberts AB, Sporn MB: Immunodetcction 
and quantitation orthe two forms oftnmsfoflning growth f.1ctor-beta (TGF-f3 1 
and TGF-(32) secreted by cdls. ) Crlll'l,ysiol 138:79-86. 1989 
27. Kane CJM. Hebda PA. Mansbl'idge JN . Hanawalt PC : Direct evidence for spatial 
aud tClllpor~al regulation uf transforming growth f.1cror-J3 1 expression during 
cutaneous wo und healing. ) Cell PIl),si()1148: 157-173. 1991 
28 . Cooper JA: Effects ofcytochalasin and phalloidin o n actin.) Cell Bi,,/ 105: 1473-
1478. 1987 
29 . Gabbiani G. H irschd BJ. Ra)", GB. Statkov PRo Majno G: Granulation tissue as 
a contractile organ. A study of structure and fun ction.) EXfI Mcd 135:7 19-734 , 
1972 
30. Lyons IlM. Keski-OjaJ, Moses HL: Proteolytic activarion oflatent transfonning 
growth r.,ctor-{3 from fibroblast-condi tioned media.) Cdl Bi()/106: 1659- 1665 . 
1988 
3 1. Oauer EA. Valle KJ, Esterly NO:' Colchicine-induced modulation of collagenase 
in hum an skin fibroblast cultures: a probe ror dcfcctive regulation in epidcr-
molysis bu11 osa.) III"cst Oenllnlol 79:403-407. 1982 
32. Aggcicr J : Cytoskc1etal dynamics in rabbit synovial fibroblasts: II. Reformation of 
stress fibers in ce lls rounded by trC:ltmcnt with collagenase-inducing agents. 
Cell MOlil C )'wskelewII 16:121-132. 1990 
33. Aggeler J , Seely K: Cytoskcletal dynamics in rabbit synovial fibroblasts: I. EHects 
of :lcrylamidc 011 intermcdiate fi laments and microtii:ll1lcnts. Cell A1,,,iJ C)IIO~ 
skelelcl/l 16: II 0-120, 1990 
34. \Verb Z , Tremble PM. Oehrendtscn O. Crowley E. Damsky CH: Signal 
transduction through the fibrollcctin receptor induces collagenase and str011lC-
lysin gene expression . ) Cell Hiol 109:877- 889. 1989 
